ApconiX was formed by three AstraZeneca colleagues with the drive and ambition to create a world-renowned company known for its expertise in nonclinical safety toxicology and ion channel electrophysiology. The company is founded on the skills and experience of a growing team with a wide range of expertise in preclinical drug safety.
ApconiX is continually forming collaborative relationships, helping customers large and small. The changing face of drug discovery and development means a safe pair of hands is needed to help companies navigate the difficult pathway towards safe, effective and profitable drugs.
ApconiX are a member of our CRO Network, part of our Virtual R&D offering. You can find out more about them on their website.
